Sg3 Management, LLC Acadia Pharmaceuticals Inc Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $84,083 - $175,922	6,463 Added 11.14%	64,500 $909,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $1.22 Million - $1.6 Million	58,037 New	58,037 $1.41 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $194,000 - $274,200	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $250,200 - $549,900	10,000 New	10,000 $258,000
Q3 2019 Nov 13, 2019	SELL	$22.22 - $44.01 $166,650 - $330,075	-7,500 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$16.17 - $27.38 $121,275 - $205,350	7,500 New	7,500 $201,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.